Early-stage, Novel and Compelling Dual-functional Drug for Improved Treatment of Resistant Colon and Lung Cancers and Chronic Myelogenous (or Myeloid) Leukemia (CML).

A compelling early stage dual functional treatment for resistant colon and lung cancers chronic myelogenous (or myeloid) leukemia with higher efficacy, lower toxicity, and greater ability to combat drug resistance than other clinically available drugs....

ShieldSTAY: An Innovative Gonadal Shield Design for Safer Radiology

ShieldSTAY is novel gonadal shield design which addresses many of the problems with current radiation shielding products, particularly for pediatric applications....

Plant Based Treatment for Liver Cirrhosis and Jaundice

Controlling excess bilirubin, SGPT and toxic effects, this treatment targets liver malfunction without the side effects...

Cholesterol and Triglyceride Treatment Without the Typical Side Effects

Available in two small capsules, this treatment proves effective against ischemic heart disease and high cholesterol....

Topical OTC (Europe) and Rx (United States) Diclofenac Pain Relief Product

Using a unique resin-based topical delivery system, this product provides more effective local pain relief and longer periods of sustained relief compared to existing products....

Nicotine Replacement Therapy Product Available to Out-license or Co-develop

This transbuccal (tiny spray on the inside of the cheek) nicotine replacement therapy (NRT) is delivered rapidly into the bloodstream where it provides immediate relief from nicotine cravings....

OTC Safe and Effective Ear Wax Remover

Our client has developed a solution to successfully prevent unwanted earwax buildup....

RhFSH Drug Substance, Highly Similar to Gonal-F®, Requiring Further Development Into Biosimilar to be Used in Fertility Treatments

A biosimilar specialist has manufactured the rhFSH API and is now looking for a partner to fully develop it into a biosimilar comparable to that of Gonal-f®...

Clinical Candidate GABA-based Compounds Based for Neuropathic Pain.

Our Eastern based client has identified a group of compounds that are effective in the treatment of neuropathic chronic pain and have no CNS-related side effects....

Patented Pre-clinical Alopecia Treatment Derived from Novel Use of Cardiac Glycosides

Our UK based client has developed and patented a unique treatment for alopecia and is seeking co-development partners. ...

Novel Anti-inflammatory Compound with Wound Healing/anaesthetic Properties Suitable for a Wide Range of Dermatological and Dental Applications.

This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market....

Adipose Tissue Derived Stem Cells Available for Development to Treat Musculoskeletal, Metabolic, Ophthalmic or Cardiovascular Related Disorders.

Our client is looking for partners to further develop and commercialize stem cells, sourced from adipose tissue for the treatment of regenerative medicine and ageing....

Small Molecule Platform Capable of Enhancing Osteogenic Differentiation of Stem Cells for the Treatment of Bone Disorders.

Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them....

Novel Anti-inflammatory Omega-3 Fatty Acids Sourced from Green Lipped Mussels.

The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients....

Omega-3 Fatty Acids to Treat Joint Care, Asthma and Dermatitis in Animals.

Our clients are sourcing and developing unique omega-3 fatty acids from green lipped mussels for the treatment of joints, asthma and dermatitis in animals....

Seeking Partners in Nigerian, Kenyan and Angolan Markets for Distribution of Prescription Pharmaceuticals

Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Nigeria, Kenya and Angola. ...

A Clinically Active Antisense Inhibitor for the Treatment of Relapsing- Remitting Multiple Sclerosis.

Our Australian based clients have developed a second generation antisense inhibitor to human CD49d, a subunit of VLA-4, that has shown in Phase II studies to be effective in reducing brain lesions in patients with the relapsing form of multiple sclerosis....

Unique “Plant Milking” Technology Capable of Producing High Value Active Cosmetic Compounds from the Roots of Rare, Protected, Slow to Grow Plant Species.

The ‘green technology’ allows the extraction of cosmetically active compounds from plants using root exudation without harming the plants involved....

Tension Free Vaginal Support (TVS) Medical Device Indicated for Stress Incontinence in Women

Women’s health specialists have created a non invasive class IIa medical device for the successful control of stress related incontinence....

Anti-microbial Monocaprin Emulsion, Available for Use as a Cleaning Solvent in the Preparation and Protection of Food, Detergents and Cosmetics.

Our client is an academic institution that has developed a unique anti-microbial monocaprin emulsion with key cleaning solvent properties indicated primarily for the preparation and protection of food and cosmetics. ...